# Severe hypotension but not systemic inflammation or endothelial activation predicts encephalopathy in circulatory shock

**Authors:** Duc Nam Nguyen, Luc Huyghens, Truc Mai Nguyen, Johan Schiettecatte, Marc Diltoer, Wilfried Cools, Helene De Cuyper, David Rhapsorski, Johan Smitz, Haibo Zhang

PMC · DOI: 10.1016/j.aicoj.2026.100033 · Annals of Intensive Care · 2026-02-18

## TL;DR

The study finds that severe low blood pressure, not systemic inflammation or blood vessel issues, is most linked to brain dysfunction in patients with circulatory shock.

## Contribution

This study identifies severe hypotension as a key predictor of encephalopathy in circulatory shock, challenging prior assumptions about systemic inflammation's role.

## Key findings

- Severe hypotension (MAP <50 mmHg) is strongly associated with encephalopathy in circulatory shock patients.
- Systemic inflammation and endothelial activation markers are not linked to encephalopathy.
- Neuroinflammation (e.g., elevated S100B) and ICU-acquired infections are also associated with encephalopathy.

## Abstract

Encephalopathy is a frequent complication of circulatory shock and is associated with adverse outcomes. Whether encephalopathy is driven primarily by systemic inflammation, endothelial activation or cerebral hypoperfusion remains uncertain.

We retrospectively studied 198 intensive care unit (ICU) patients with circulatory shock (95 septic shock, 103 non-septic shock). Encephalopathy (coma and delirium) was assessed using the Glasgow Coma Scale, Richmond Agitation-Sedation Scale, and Confusion Assessment Method for the ICU. Neuroinflammation or blood-brain barrier (BBB) dysfunction was evaluated using serum S100B protein. Systemic inflammation and endothelial activation were assessed using serum C-reactive protein (CRP), Matrix metalloproteinase-9 (MMP-9), Intercellular Adhesion Molecule -1 (ICAM-1) and Vascular Endothelial Growth Factor (VEGF). Severe hypotension was defined a priori as mean arterial pressure (MAP) <50 mmHg sustained ≥1 min; we also quantified the number of episodes and cumulative duration of MAP <60 and <50 mmHg across the first 72 h. Multivariable logistic regression and mixed-effect models examined associations with encephalopathy and ICU outcomes.

Encephalopathy developed in 140 patients (71%): 31 (23%) with coma and 99 (71%) with delirium. Severe hypotension (OR: 2.56 (1.18, 4.75), p = 0.022), longer sedation duration (OR: 1.09 (1.02, 1.18), p = 0.017), ICU-acquired infections (OR: 1.61(0.73, 3.54), p = 0.021), and elevated S100B (OR: 1.72 (0.66, 3.65), p = 0.03) were associated with encephalopathy. In contrast, systemic inflammation (CRP, MMP-9) and endothelial activation (ICAM-1, VEGF) were not associated with encephalopathy. Despite higher systemic inflammation in septic shock, the prevalence of encephalopathy and structural brain injury was similar to non-septic shock.

In circulatory shock, encephalopathy is most strongly associated with recurrent/severe hypotension (MAP <50 mmHg) and markers of neuroinflammation, not systemic inflammation or endothelial activation.

## Linked entities

- **Proteins:** S100B (S100 calcium binding protein B)
- **Diseases:** encephalopathy (MONDO:0005560), coma (MONDO:0009764), delirium (MONDO:0045057)

## Full-text entities

- **Genes:** IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, MOK (MOK protein kinase) [NCBI Gene 5891] {aka RAGE, RAGE-1, RAGE1, STK30}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, S100B (S100 calcium binding protein B) [NCBI Gene 6285] {aka NEF, S100, S100-B, S100beta}
- **Diseases:** drug intoxication (MESH:D000435), dementia (MESH:D003704), Systemic (MESH:D015619), postpartum hemorrhage (MESH:D006473), post-cardiac arrest (MESH:D000080942), heart failure (MESH:D006333), Coma (MESH:D003128), gastrointestinal bleeding (MESH:D006471), Sepsis (MESH:D018805), NS (MESH:D012772), neuromuscular disease (MESH:D009468), Septic (MESH:D001170), hypertension (MESH:D006973), brain injury (MESH:D001930), Encephalopathy (MESH:D001927), neurological injury (MESH:D020196), CS (MESH:D006223), intracerebral/subarachnoid hemorrhage (MESH:D013345), hypovolemic (MESH:D020896), encephalitis (MESH:D004660), infections (MESH:D007239), ischemic strokes (MESH:D002544), end-stage organ failure (MESH:D007676), post-cardiotomy syndrome (MESH:D000094025), ischemic lesions (MESH:D017202), delirium (MESH:D003693), diarrhea (MESH:D003967), stroke (MESH:D020521), hemorrhage (MESH:D006470), neurological diseases (MESH:D020271), obesity (MESH:D009765), Organ Failure (MESH:D009102), anaphylactic shock (MESH:D000707), burns (MESH:D002056), ischemia (MESH:D007511), Hypotension (MESH:D007022), neurological disorders (MESH:D009461), pulmonary embolism (MESH:D011655), hyperactive (MESH:D006948), fluid loss (MESH:D002559), acute coronary syndrome (MESH:D054058), inflammation (MESH:D007249), Comorbidity (MESH:D004194), Hypovolemic shock (MESH:D012769), cardiogenic (MESH:D013575), Cerebral hypoperfusion (MESH:D002547), HS (MESH:C567159), BBB (MESH:C536830), pancreatitis (MESH:D010195), Neuroinflammation (MESH:D000090862), atrophy (MESH:D001284), meningitis (MESH:D008580), Neurological complications (MESH:D002493), Cardiogenic shock (MESH:D012770), neurotoxic (MESH:D020258), Failure (MESH:D051437), polytrauma (MESH:D009104), malignancy (MESH:D009369), aortic dissection (MESH:D000784)
- **Chemicals:** reactive oxygen species (MESH:D017382), morphine (MESH:D009020), heparin (MESH:D006493), alcohol (MESH:D000438), remifentanil (MESH:D000077208), norepinephrine (MESH:D009638), propofol (MESH:D015742), glutamate (MESH:D018698), midazolam (MESH:D008874), lactate (MESH:D019344)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12934433/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12934433/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12934433/full.md

---
Source: https://tomesphere.com/paper/PMC12934433